Related Experiment Video
Updated: Sep 28, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Field cancerization in breast cancer
Emanuela Gadaleta1, Graeme J Thorn1, Helen Ross-Adams1
1Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK.
Breast cancer recurrence may stem from molecularly altered cells in surrounding healthy tissues, not just tumor spread. Analyzing these peri-tumoral tissues could improve risk assessment and patient treatment strategies.
Area of Science:
- Oncology
- Pathology
- Genomics
Background:
- Breast cancer recurrence affects up to 15% of patients within 10 years post-surgery.
- Traditional monitoring focuses on the primary tumor, overlooking molecular changes in surrounding tissues.
- The field cancerization theory suggests tumors arise from a field of altered cells creating a permissive environment.
Purpose of the Study:
- To explore the concept of field cancerization in histologically normal (HN) peri-tumoral breast tissues.
- To present pathological and molecular features of field cancerization in these tissues.
- To discuss the impact of peri-tumoral tissue analysis on breast cancer research and patient management.
Main Methods:
- Review of existing literature on field cancerization in breast cancer.
- Analysis of pathological and molecular features in HN peri-tumoral tissues.
- Discussion of diagnostic challenges due to inter-patient variability in normal breast tissue.
Main Results:
- Identified distinct molecular aberrations in peri-tumoral tissues beyond the primary tumor.
- Highlighted the potential for a 'field of cancerization' in histologically normal tissue.
- Acknowledged challenges in recognizing cancerization due to normal tissue variability.
Conclusions:
- Pathological and molecular evaluations of peri-tumoral tissues are crucial for understanding recurrence.
- Synergistic use of pathological and molecular data can improve risk assessment.
- This approach may guide more effective therapeutic management for breast cancer patients.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

